2024-11-14T13:13:41-06:00 2023-12-31 221478099 COHNREZNICK LLP 7501 WISCONSIN AVENUE SUITE 400E BETHESDA MD 20814 990 2023-01-01 833561693 ASCO ASSOCIATION ASCO 5714831300 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 MELINDA O'LEARY CFO 5714831300 2024-11-14 1 1 LORI ROTHE YOKOBOSKY CPA P01273422 3016529100 2024-11-13 2023 2024-10-15 13:58:12Z ASSOCIATION FOR CLINICAL ONCOLOGY CLIFFORD HUDIS MD CEO 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 17408296 0 X WWW.ASCOASSOCIATION.ORG X 2019 VA OUR MISSION IS TO CONQUER CANCER THROUGH ADVOCACY FOR RESEARCH, EDUCATION, AND THE PROMOTION OF THE HIGHEST QUALITY, EQUITABLE PATIENT CARE. 11 11 47 4011 408645 275669 58500 933505 15152807 16132753 4083 134364 232615 207674 15448005 17408296 145667 138592 0 0 6166450 7273510 0 0 0 7994613 7643643 14306730 15055745 1141275 2352551 4082175 5377567 13328762 12210976 -9246587 -6833409 X ASCO ASSOCIATION PROMOTES THE COMMON BUSINESS INTERESTS OF ITS MEMBERS BY: (1) ADVOCATING FOR POLICIES THAT IMPROVE THE QUALITY OF CANCER CARE; (2) MAINTAINING THE HIGHEST STANDARDS OF ONCOLOGY MEDICAL CARE THROUGH PROGRAMS SUPPORTING EDUCATION, (CONTINUED IN SCHEDULE O) RESEARCH, AND QUALITY IMPROVEMENT; AND (3) INCREASING AWARENESS AMONG THE MEDICAL COMMUNITY, PATIENTS, AND THE PUBLIC OF CHALLENGES FACED BY ONCOLOGY MEDICAL PROFESSIONALS THAT MAY AFFECT QUALITY OF CANCER CARE. 0 0 SEE SCHEDULE O:MEMBER SERVICES: THE ASSOCIATION WORKS TO SUPPORT AND EDUCATE ITS GLOBAL NETWORK OF NEARLY 45,000 ONCOLOGY PROFESSIONAL MEMBERS, MAINTAINING ONLINE FORUMS THAT ALLOW MEMBERS TO DISCUSS ISSUES OF PROFESSIONAL INTEREST, SUPPORTING INTERNATIONAL REGIONAL COUNCILS, AND RECRUITING MEMBERS FOR, AND TRACKING PARTICIPATION IN, VOLUNTEER ACTIVITIES RELATED TO THE ASSOCIATION, INCLUDING SERVING ON COMMITTEES. SEE SCHEDULE O:ACCREDITATION & CERTIFICATION: THE ASSOCIATION CONDUCTS AN ACCREDITATION PROGRAM THAT PROMOTES THE PRACTICE OF ITS MEMBERS BY MAINTAINING AND IMPROVING THE QUALITY OF MEDICAL CARE AVAILABLE TO THE PUBLIC AND MAINTAINING HIGH STANDARDS OF EXCELLENCE IN ONCOLOGY.THE QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) CERTIFICATION PROGRAM ("QCP") PROVIDES A THREE-YEAR CERTIFICATION RECOGNIZING HIGH-QUALITY AND SAFE CARE FOR OUTPATIENT HEMATOLOGY-ONCOLOGY PRACTICES. THE QCP STANDARDS WERE ADAPTED FROM THE CHEMOTHERAPY ADMINISTRATION SAFETY STANDARDS CODEVELOPED BY ASCO AND THE ONCOLOGY NURSING SOCIETY (ONS). THEY ARE INTENDED TO PROVIDE SAFTEY TO BOTH PATIENTS AND THE CARE DELIVERY STAFF BY REDUCING THE RISK OF ERRORS AND PROMOTING THE SAFE HANDLING OF CHEMOTHERAPY AGENTS. PARTICIPATING PRACTICES RECEIVE SITE SURVEYS BY EXPERIENCED ONCOLOGY PROFESSIONALS TO ASSESS COMPLIANCE WITH ALL QCP STANDARDS THROUGH INTERVIEWS, OBSERVATION, AND MEDICAL RECORD REVIEWS. PARTICIPANTS RECEIVE REPORTS DOCUMENTING THEIR LEVEL OF COMPLIANCE WITH EACH CERTIFICATION STANDARD AND MAKING RECOMMENDATIONS OR REQUIREMENTS FOR IMPROVED CARE. QCP CERTIFICATION RECOGNIZES HIGH PERFORMING PRACTICES AND IS NOT REQUIRED FOR ANY PROFESSIONAL LICENSING, NOR IS IT REQUIRED OF THE ASSOCIATION'S MEMBERS. 273 HEMATOLGY-ONCOLOGY PRACTICES ARE ACTIVELY CERTIFIED IN 2023.THE ASSOCIATION LAUNCHED A NEW QUALITY CERTIFICATION PROGRAM IN 2023, ASCO CERTIFIED. THIS CERTIFICATION RECOGNIZES PATIENT CENTERD CANCER CARE DELIVERY ADHERING TO THE ONCOLOGY MEDICAL HOME STANDARDS CODEVELOPED BY ASCO AND THE COMMUNITY ONCOLGY ALLIANCE (COA). SIMILAR TO QCP, PARTICIPATING PRACTICES RECEIVE SITE SURVEYS BY EXPERIENCED ONCOLOGY PROFESSIONALS TO ASSESS COMPLIANCE WITH ALL ASCO CERTIFIED STANDARDS THROUGH INTERVIEWS, OBSERVATION, AND MEDICAL RECORD REVIEWS. PARTICIPANTS RECEIVE REPORTS DOCUMENTING THEIR LEVEL OF COMPLIANCE WITH EACH CERTIFICATION STANDARD AND MAKING RECOMMENDATIONS OR REQUIREMENTS FOR IMPROVED CARE. ONCE CERTIFIED PARTICANTS ARE MONITORED ANNUALLY FOR CONTINUOUS QAUALITY IMPROVEMENT AND RESURVEYED EVERY 3 YEARS. ASCO CERTIFIED IS NOT REQUIRED FOR ANY PROFESSIONAL LICENSING, NOR IS IT REQUIRED OF THE ASSOCIATION'S MEMBERS. 12 HEMATOLOGY-ONCOLOGY PRACTICES ACHIEVED CERTIFICATION IN 2023. SEE SCHEDULE O:ADVOCACY: THE ASSOCIATION'S ADVOCACY WORK FOCUSES ON ASSURING HIGH-QUALITY CARE FOR ALL PATIENTS WITH CANCER. WORKING WITH VOLUNTEER MEMBERS AND AFFILIATED STATE AND REGIONAL ONCOLOGY SOCIETIES, ASCO ENGAGES WITH THE ADMINISTRATION, CONGRESS, AND STATE LAWMAKERS TO ADDRESS ISSUES OF CRITICAL IMPORTANCE TO CANCER CARE AND RESEARCH. THE ASSOCIATION'S ADVOCACY PORTFOLIO INCLUDES CLINICAL RESEARCH, INSURANCE, CLINICAL PRACTICE, WORKFORCE, DISPARITIES, COST AND ACCESS, SURVIVORSHIP, AND CANCER PREVENTION. ADVOCACY ACTIVITIES INCLUDE TRACKING, ANALYZING, AND INFLUENCING PENDING LEGISLATION AND REGULATIONS, AND EDUCATING BOTH MEMBERS AND POLICYMAKERS ABOUT THE IMPACT OF POLICY ON CANCER PATIENTS, CLINICIANS, AND CLINICAL RESEARCH. IN 2023, ASCO WAS INVITED TO TESTIFY BEFORE THE HOUSE ENERGY AND COMMERCE COMMITTEE, THE HOUSE WAYS AND MEANS COMMITTEE, AND THE SENATE FINANCE COMMITTEE ON ISSUE OF IMPORTANCE TO CANCER CARE AND RESEARCH, INCLUDING THE DRUG SHORTAGE CRISIS AND THE NEED TO SUSTAIN A NATIONAL RESEARCH ENTERPRISE. 0 1 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 23 0 1 47 1 1 1 0 0 0 1 1 0 0 0 X 11 11 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 0 VA X MELINDA O'LEARY CFO 5714831300 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 EVERETT E VOKES MD BOARD CHAIR (PARTIAL YEAR) 1.00 1.00 X X 0 0 0 LORI J PIERCE MD BOARD CHAIR (PARTIAL YEAR) 1.00 1.00 X X 0 0 0 BRIAN EDWARD PERSING MD TREASURER (PARTIAL YEAR) 1.00 X X 0 0 0 JASON R WESTIN MD MS TREASURER (PARTIAL YEAR) 1.00 X X 0 0 0 ETHAN M BASCH MD MSC BOARD MEMBER (PARTIAL YEAR) 1.00 X 0 0 0 LISA A CAREY MD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 XYLINA T GREGG MD BOARD MEMBER (PARTIAL YEAR) 1.00 X 0 0 0 TARA O HENDERSON MD MPH BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 ELIZABETH A MITTENDORF MD PHD MHC BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 TAOFEEK K OWONIKOKO MD PHD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 ELIZABETH R PLIMACK MD MS BOARD MEMBER 1.00 1.00 X 0 0 0 LYNN M SCHUCHTER MD BOARD MEMBER 1.00 2.00 X 0 0 0 ENRIQUE SOTO PEREZ DE CELIS MD MSC BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 PIYUSH SRIVASTAVA MD BOARD MEMBER (PARTIAL YEAR) 1.00 X 0 0 0 MICHAEL A THOMPSON MD PHD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 ERIC P WINER MD BOARD MEMBER 1.00 1.00 X 0 0 0 ROBIN ZON MD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 CLIFFORD A HUDIS CEO 1.00 36.50 X 0 1060801 24750 LINDA A JENSEN CFO 1.00 36.50 X 0 477532 42792 MELISSA TAI SECRETARY 8.00 29.50 X 0 350115 49281 KRISTA BARNES VICE PRESIDENT, MEMBER SERVICES 19.00 18.50 X 302663 0 47169 JENNIFER BRUNELLE CHIEF ADVOCACY OFFICER 37.50 X 258709 0 43569 KAREN HAGERTY CHIEF REGULATORY AFFAIRS OFFICER 37.50 X 245179 0 26560 RONDA BOWMAN SENIOR DIRECTOR, QCP 37.50 X 213046 0 30341 TERRY COX DIRECTOR, AFFILIATE RELATIONS 37.50 X 161700 0 30417 SHIMERE SHERWOOD DIRECTOR, SCIENCE & RESEARCH POLICY 37.50 X 174380 0 12375 KRISTINE RUFENER DIRECTOR, CONGRESSIONAL AFFAIRS 37.50 X 161472 0 37044 1517149 1888448 344298 18 0 1 0 WOLTERS KLUWER HEALTH 351 WEST CAMDEN ST BALTIMORE MD 21201 DESIGN, PRINT, MAIL 2526126 QUAD GRAPHICS INC 160 CENTURY LANE WINCHESTER VA 22603 DESIGN, PRINT, MAIL 249035 TIBER CREEK GROUP INC 750 9TH ST NW SUITE 501 WASHINGTON DC 20001 PUBLIC AFFAIRS 240000 HBP INC 2818 FALLFAX DRIVE FALLS CHURCH VA 22042 DESIGN, PRINT, MAIL 128290 MCI GROUP ASIA PACIFIC PTE LTD 20 BENDEMEER RD 04-02 SN 339914 MARKETING 122820 5 878805 54700 933505 MEMBER DUES 813920 14186963 14186963 CERTIFICATION INCOME 813920 1075887 1075887 MEMBER SERVICES 813920 461258 461258 ADVERTISING 541800 408645 408645 16132753 134364 134364 207674 207674 17408296 15724108 408645 342038 X 138592 326654 5684695 323878 570173 368110 75354 240000 1775520 361337 291235 832636 648826 PRINTING, POSTAGE & PRO 2845732 BANK & CREDIT CARD FEES 373431 UBI TAX 199572 15055745 1795125 3380533 166835 171520 105651 42173 2014564 1783341 4082175 5377567 302756 454050 11990236 11277996 1035770 478930 13328762 12210976 X -9246587 -6833409 -9246587 -6833409 4082175 5377567 2352551 60627 0 X X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 14105525 500296 500296 1128442 -628146 0 DUE TO ASCO 478930 478930 X PART X, LINE 2: IN PART: THE ASSOCIATION IS A NON-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(6) OF THE IRC AS A TRADE ASSOCIATION. QCP IS A DISREGARDED ENTITY AND INCLUDED IN THE ASSOCIATION'S INCOME TAX RETURN. THE PAC IS A SEPARATE SEGREGATED FUND OF THE ASSOCIATION CLASSIFIED UNDER SECTION 527 OF THE IRC. THE ASSOCIATION RECEIVED TAXABLE REVENUE RELATED TO ADVERTISING. THE ORGANIZATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE INCOME TAX TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS BOARD ACCOUNTING STANDARDS CODIFICATION ("FASB ASC"). THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. GENERALLY, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2020. EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES 165957 SOUTH AMERICA 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES 51717 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES 16467 0 0 0 0 0 0 234141 0 234141 0 0 0 0 0 1 PART I, LINE 3: THE ACCRUAL METHOD IS USED TO TRACK AND ACCOUNT FOR FOREIGN EXPENDITURES. 1 REGENTS OF THE UNIVERSITY OF MICHIGAN G395 WOLVERINE TOWER LOW RISE ANN ARBOR MI 48109 386006309 501(C)(3) 15000 0 CANCER RESEARCH THE LEUKEMIA & LYMPHOMA SOCIETY 3 INTERNATIONAL DR SUITE 200 RYE BROOKE NY 10573 135644916 501(C)(3) 21942 0 CANCER RESEARCH UNIVERSITY OF CHICAGO 6054 S DREXEL AVENUE SUITE 300 CHICAGO IL 60637 362177139 501(C)(3) 15000 0 CANCER RESEARCH 3 0 PART I, LINE 2: GRANTS ARE MADE TO SELECT ORGANIZATIONS WHOSE MISSION INVOLVES CANCER CARE, EDUCATION OR RESEARCH. GRANTS ARE DESIGNATED FOR SCIENTIFIC, EDUCATIONAL OR RESEARCH PURPOSES. 0 0 0 CLIFFORD A HUDIS CEO 0 1049613 0 10000 0 1188 24750 0 0 0 24750 1060801 0 0 LINDA A JENSEN CFO 0 463824 0 10000 0 3708 0 24750 0 18042 0 520324 0 0 MELISSA TAI SECRETARY 0 339395 0 10450 0 270 0 24750 0 24531 0 399396 0 0 KRISTA BARNES VICE PRESIDENT, MEMBER SERVICES 292249 0 10000 0 414 0 22500 0 24669 0 349832 0 0 0 JENNIFER BRUNELLE CHIEF ADVOCACY OFFICER 247239 0 11200 0 270 0 18900 0 24669 0 302278 0 0 0 KAREN HAGERTY CHIEF REGULATORY AFFAIRS OFFICER 233205 0 11200 0 774 0 17561 0 8999 0 271739 0 0 0 RONDA BOWMAN SENIOR DIRECTOR, QCP 203358 0 8500 0 1188 0 15750 0 14591 0 243387 0 0 0 KRISTINE RUFENER DIRECTOR, CONGRESSIONAL AFFAIRS 154610 0 6700 0 162 0 12375 0 24669 0 198516 0 0 0 TERRY COX DIRECTOR, AFFILIATE RELATIONS 160086 0 1200 0 414 0 12375 0 18042 0 192117 0 0 0 SHIMERE SHERWOOD DIRECTOR, SCIENCE & RESEARCH POLICY 165000 0 9200 0 180 0 12375 0 0 0 186755 0 0 0 PART I, LINE 3 COMPENSATION FOR THE CEO IS ESTABLISHED BY THE ASSOCIATION'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (SOCIETY), A SECTION 501(C)(3) ORGANIZATION. THE METHODS USED BY THE SOCIETY IN DETERMINING THE CEO'S COMPENSATION INCLUDE COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, FORM 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD AND COMPENSATION COMMITTEE. UNDER A SHARED SERVICES AGREEMENT BETWEEN THE SOCIETY AND THE ASSOCIATION, THE ASSOCIATION PAYS THE SOCIETY FOR TIME SPENT BY THE CEO ON ASSOCIATION MATTERS. FORM 990, PART VI, SECTION A, LINE 1A DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH THE ASSOCIATION'S BYLAWS. PURSUANT TO THE BYLAWS, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE ARE THE CHAIR, TREASURER, AND ONE OR MORE VOTING MEMBERS OF THE BOARD OF DIRECTORS. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF THE ASSOCIATION'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY THE ASSOCIATION'S EXECUTIVE COMMITTEE CHARTER, WHICH WAS APPROVED BY THE ASSOCIATION'S BOARD OF DIRECTORS. THE CHARTER PROVIDES THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY THE BYLAWS, RESOLUTION OF THE BOARD OF DIRECTORS, OR APPLICABLE LAW, THE EXECUTIVE COMMITTEE IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT MEETING OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 6 NONE OF THE ASSOCIATION'S MEMBERS HAS THE RIGHT TO RECEIVE A SHARE OF THE ORGANIZATION'S PROFITS OR EXCESS DUES OR A SHARE OF THE ORGANIZATION'S NET ASSETS UPON DISSOLUTION. MEMBERSHIP IS LIMITED TO ONCOLOGY MEDICAL PROFESSIONALS, DEFINED AS INDIVIDUALS WHOSE PROFESSIONAL CREDENTIALS AND ACTIVITIES INVOLVE CANCER PATIENT CARE AND/OR RESEARCH, EDUCATION, OR ADVOCACY IN THE BIOLOGY, DIAGNOSIS, PREVENTION, OR TREATMENT OF HUMAN CANCER; THOSE INDIVIDUALS WHO ARE RETIRED FROM PROFESSIONAL ACTIVITIES, BUT WHOSE PROFESSIONAL ACTIVITIES PRIOR TO RETIREMENT INCLUDED THOSE DESCRIBED ABOVE; AND THOSE INDIVIDUALS WHO ARE STUDENTS TRAINING TO BE PROFESSIONALS DESCRIBED ABOVE. THE CATEGORY OF MEMBERSHIP WITH VOTING RIGHTS IS VOTING MEMBERS, WHO ARE DEFINED AS THOSE ONCOLOGY MEDICAL PROFESSIONAL MEMBERS THAT HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE. FORM 990, PART VI, SECTION A, LINE 7A ALL ASCO MEMBERS ARE MEMBERS OF BOTH THE ASSOCIATION AND ITS AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (THE SOCIETY). VOTING MEMBERS OF ASCO ELECT ALL MEMBERS OF THE SOCIETY BOARD OF DIRECTORS. THE MEMBERS OF THE SOCIETY BOARD OF DIRECTORS WHO ARE IN THE FINAL YEAR OF THEIR TERMS, AND THE SOCIETY'S ELECTED OFFICERS, WHO ARE ALL ELECTED BY THE ASCO VOTING MEMBERS, SERVE AS EX-OFFICIO VOTING MEMBERS OF THE ASSOCIATION BOARD OF DIRECTORS. THE CATEGORY OF ASCO MEMBERS WHO ARE ELIGIBLE TO VOTE FOR THE ELECTION OF MEMBERS OF THE SOCIETY BOARD OF DIRECTORS ARE VOTING MEMBERS, WHO ARE DEFINED AS THOSE ONCOLOGY MEDICAL PROFESSIONAL MEMBERS THAT HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE. FORM 990, PART VI, SECTION A, LINE 7B VOTING MEMBERS HAVE THE RIGHT TO VOTE ON CHANGING THE PURPOSE OF THE ASSOCIATION (AS SET FORTH IN THE BYLAWS), VOLUNTARY DISSOLUTION OF THE ASSOCIATION, AND ANY SUCH MATTERS THAT THE BOARD OF DIRECTORS BRINGS TO THE MEMBERSHIP FOR VOTE. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT ELECTRONIC COPY OF THE ASSOCIATION'S FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS. IN ADDITION, BEFORE FILING, THE FORM WAS REVIEWED BY THE CFO AND CHIEF LEGAL OFFICER. FORM 990, PART VI, SECTION B, LINE 12C THE ASSOCIATION MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASSOCIATION MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. THE ASSOCIATION'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF THE ASSOCIATION WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. A BOARD MEMBER, DIRECTOR, PRINCIPAL OFFICER, OR KEY EMPLOYEE WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15B THE COMPENSATION OF THE ASSOCIATION'S CHIEF FINANCIAL OFFER WAS REVIEWED AND APPROVED BY INDEPENDENT PERSONS ON THE BASIS OF COMPARABILITY DATA, AND THE DELIBERATION AND DECISION WAS CONTEMPORANEOUSLY SUBSTANTIATED. THE COMPENSATION OF THE ASSOCIATION'S SECRETARY AND VICE PRESIDENT, MEMBER SERVICES WAS REVIEWED AND APPROVED USING COMPARABILITY DATA. THE ASSOCIATION'S COMPENSATION CONSULTANT, BASED ON THE ROLE'S RESPONSIBILITIES AND COMPARABILITY DATA, PROVIDED REASONABLENESS ASSURANCE FOR SUCH COMPENSATION. THIS REVIEW WAS LAST CONDUCTED IN 2023. FORM 990, PART VI, SECTION C, LINE 19 THE ASSOCIATION'S ARTICLES OF INCORPORATION ARE AVAILABLE ON THE VIRGINIA STATE CORPORATION COMMISSION WEBSITE. THE ASSOCIATION MAKES ITS BYLAWS AVAILABLE UPON REQUEST. THE ASSOCIATION'S CONFLICT OF INTEREST POLICY IS AVAILABLE ON THE ASCO WEBSITE. THE ASSOCIATION'S FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART VI, SECTION B, LINE 15A THE CHIEF EXECUTIVE OFFICER OF THE ASSOCIATION IS AN EMPLOYEE OF THE ASSOCIATION'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (THE SOCIETY). INFORMATION REGARDING HIS COMPENSATION AND THE PROCESS FOR DETERMINING HIS COMPENSATION, INCLUDING REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, ARE DESCRIBED IN THE IRS FORM 990 OF THE SOCIETY. THE ASSOCIATION REIMBURSES THE SOCIETY FOR TIME SPENT ON ASSOCIATION MATTERS IN ACCORDANCE WITH A SHARED SERVICES AGREEMENT BETWEEN THE ENTITIES. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL SERVICES 1,775,520. QOPI CERTIFICATION PROGRAM LLC 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 271629211 ACCREDITATION VA 1075887 89450 ASCO ASSOCIATION AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 136180380 RESEARCH/EDUCATION NY 501(C)(3) LINE 10 N/A 0 CONQUER CANCER FOUNDATION OF ASCO 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 311667995 GRANTS VA 501(C)(3) LINE 7 ASCO 0 ASCO ASSOCIATION POLITICAL ACTION COMM 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 844213157 ADVOCACY VA 527 ASCO ASSOC 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 0 0